These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33331968)

  • 1. Integrating public health policies in the epidemiological modeling of hepatitis C with LEHC tool: application in Austria.
    Lopes H; Baptista-Leite R; Franco D; Pirker R; Gschwantler M
    Wien Klin Wochenschr; 2021 May; 133(9-10):461-469. PubMed ID: 33331968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let's End HepC: Modelling Public Health Epidemiological Policies Applied to Hepatitis C in Spain.
    Lopes H; Baptista-Leite R; Franco D; Serra MA; Escudero A; Martín-Moreno JM
    Front Public Health; 2021; 9():735572. PubMed ID: 35071151
    [No Abstract]   [Full Text] [Related]  

  • 3. Modeling the Puzzle of Hepatitis C Epidemiology in Romania: A Pathway to Control.
    Lopes H; Baptista-Leite R; Franco D; Eclemea I; Bratu EC; Furtunescu FL; Pop CS; Pana BC
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):377-384. PubMed ID: 32830821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
    Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
    J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
    Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
    J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global timing of hepatitis C virus elimination in high-income countries.
    Razavi H; Sanchez Gonzalez Y; Yuen C; Cornberg M
    Liver Int; 2020 Mar; 40(3):522-529. PubMed ID: 31815353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
    Fadnes LT; Aas CF; Vold JH; Ohldieck C; Leiva RA; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA;
    BMC Infect Dis; 2019 Nov; 19(1):943. PubMed ID: 31703669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gender lens is needed in hepatitis C elimination research.
    Larney S; Madden A; Marshall AD; Martin NK; Treloar C
    Int J Drug Policy; 2022 May; 103():103654. PubMed ID: 35306279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
    Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
    Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T'N'T HepC).
    Lazarus JV; Øvrehus A; Demant J; Krohn-Dehli L; Weis N
    BMJ Open; 2020 Nov; 10(11):e039724. PubMed ID: 33168560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID-19.
    Blach S; Blomé M; Duberg AS; Jerkeman A; Kåberg M; Klasa PE; Lagging M; Razavi-Shearer D; Razavi H; Aleman S
    Liver Int; 2021 Sep; 41(9):2024-2031. PubMed ID: 34051065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs.
    Midgard H; Finbråten AK; Malme KB; Berg-Pedersen RM; Tanum L; Olsen IC; Bjørnestad R; Dalgard O
    Trials; 2020 Jun; 21(1):524. PubMed ID: 32539853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study.
    Safreed-Harmon K; Hetherington KL; Aleman S; Alho H; Dalgard O; Frisch T; Gottfredsson M; Weis N; Lazarus JV;
    PLoS One; 2018; 13(1):e0190146. PubMed ID: 29381697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy.
    Bird K; Socías ME; Ti L
    Int J Drug Policy; 2018 Sep; 59():1-2. PubMed ID: 29960218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?
    Martin NK; Boerekamps A; Hill AM; Rijnders BJA
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25062. PubMed ID: 29633560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress towards hepatitis C virus elimination in high-income countries: An updated analysis.
    Gamkrelidze I; Pawlotsky JM; Lazarus JV; Feld JJ; Zeuzem S; Bao Y; Gabriela Pires Dos Santos A; Sanchez Gonzalez Y; Razavi H
    Liver Int; 2021 Mar; 41(3):456-463. PubMed ID: 33389788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
    Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
    Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Echevarria D; Gutfraind A; Boodram B; Layden J; Ozik J; Page K; Cotler SJ; Major M; Dahari H
    Vaccine; 2019 May; 37(19):2608-2616. PubMed ID: 30962092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.
    Fraser H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P
    Addiction; 2018 Nov; 113(11):2118-2131. PubMed ID: 29781207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.